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The insulin-like growth factors (IGFs) play a major role in regulating the systemic growth of mammals. However, it is unclear to what extent
their systemic and/or local functions act in concert with other local growth factors controlling the sizes of individual organs. We have specifically
addressed whether growth control of the skeleton by IGFs interacts genetically with that by Indian hedgehog (Ihh), a locally produced growth
signal for the endochondral skeleton. Here, we report that disruption of both IGF and Ihh signaling resulted in additive reduction in the size of the
embryonic skeleton. Thus, IGF and Ihh signaling appear to control the growth of the skeleton in parallel pathways.
© 2006 Elsevier Inc. All rights reserved.Keywords: Ihh; Smo; IGF; IGF1R; Growth; Skeleton; Mouse1. Introduction
The mechanisms controlling the body size of mammals are
not well understood. The growth of a mammal occurs
throughout embryogenesis and continues postnatally to reach
a steady state (Efstratiadis, 1998). The insulin-like growth
factors (IGF1 and IGF2) are major growth-promoting signals
for both embryonic and postnatal development. Whereas IGF2
is essential for normal embryonic growth (DeChiara et al., 1990,
1991), IGF1 appears to control body size throughout develop-
ment (Baker et al., 1993; Liu et al., 1993). In regulating
postnatal growth, IGF1 functions both as an effector for growth
hormone (GH) as well as by a GH-independent mechanism
(Lupu et al., 2001). Overall, genetic evidence supports the
conclusion that a GH-IGF signaling system plays a predominant
role in determining body size in mammals.
Both circulating and locally produced IGF1 may contribute
to growth regulation. The original “somatomedin hypothesis”⁎ Corresponding author. Campus Box 8301, Washington University Medical
School, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
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IGF1 which in turn affects local tissues (Salmon and Daugha-
day, 1957), but more recent evidence indicates that locally
produced IGF1 may exert paracrine or autocrine functions on
target tissues. In support of the endocrine role of IGF1,
reduction of the circulating IGF1 level to 10–15% of normal by
removal of the acid labile subunit (ALS) (which helps to
stabilize serum IGF1 levels) along with ablation of Igf1
expression in the liver resulted in significant growth retardation
in postnatal mice (Yakar et al., 2002), even though the liver-
specific deletion of Igf1 alone (resulting in serum IGF1 levels
~25% of normal) did not significantly affect growth (Sjogren
et al., 1999; Yakar et al., 1999).
IGF1 and IGF2 are known to signal through the type I IGF
receptor (IGF1R) in target tissues, as demonstrated by genetic
studies. Deletion of Igf1r (Igf1rn/n) resulted in lethality at birth,
as well as more severe growth deficiency (45% of normal
weight) than that caused by Igf1 or Igf2 deletion (60% of
normal weight) (Baker et al., 1993; Liu et al., 1993).
Importantly, Igf1n/n; Igf1rn/n double-mutant mice phenocopied
the growth defect of Igf1rn/n animals, whereas deletion of both
Igf2 and Igf1r caused a more severe growth deficiency than
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et al., 1993). Thus, IGF1R mediates all activities of IGF1, as
well as a major portion of IGF2 signaling.
Consistent with its role as a systemic growth regulator, IGF
signaling has been implicated in skeletal growth. IGF1R is
expressed in both chondrocytes and osteoblasts of the
developing skeleton (Wang et al., 1995). The Igf1rn/n embryos
exhibited a smaller skeleton associated with significant delays
in ossification (Liu et al., 1993). Moreover, postnatal analyses
of the surviving Igf1n/n mice revealed a reduction in the size of
hypertrophic chondrocytes (Lupu et al., 2001; Wang et al.,
1999). However, the relationship between IGF and other growth
regulators in the skeleton is unclear.
Indian hedgehog (Ihh) is a locally produced signal critical for
development of the endochondral skeleton. While it is produced
by prehypertrophic and early hypertrophic chondrocytes, Ihh
signals to both chondrocytes and the overlying perichondrium
(St-Jacques et al., 1999; Vortkamp et al., 1996).Mice lacking Ihh
(Ihhn/n) exhibited a severe growth deficiency in the endochon-
dral skeleton; skeletal elements were only about 20% of their
normal size at birth (St-Jacques et al., 1999). Detailed analyses
of the Ihhn/n mice revealed profound defects in chondrocyte
proliferation and maturation, as well as osteoblast formation, all
contributing to the reduction in skeletal size (St-Jacques et al.,
1999). Moreover, chondrocyte-specific deletion of Ihh recapi-
tulated all skeletal defects as observed in the Ihhn/n mutant
(Razzaque et al., 2005). These studies established Ihh as a potent
local growth signal for the endochondral skeleton.
The intracellular transduction of all Hh signals requires the
activity of a seven-pass transmembrane protein Smoothened
(Smo) (Alcedo et al., 1996; van den Heuvel and Ingham, 1996;
Zhang et al., 2001). Genetic manipulation of Smo in the
skeleton further revealed that, whereas Ihh directly controls
chondrocyte proliferation and osteoblast differentiation, it
appears to regulate chondrocyte maturation via a secondary
signal (Long et al., 2001, 2004), most likely the parathyroid
hormone related peptide (Pthlh) (Karp et al., 2000), in
agreement with a model proposed from earlier genetic and in
vitro analyses (Vortkamp et al., 1996).
In the present study, we sought to determine whether IGF
signals regulate skeletal growth by modulating Ihh signaling.
Our results support the conclusion that the two signaling
systems likely function independently in skeletal cells.
2. Materials and methods
2.1. Mouse strains
All mouse strains including Ihhn/wt, Igf1rn/wt, Igf1rc/c, Smon/wt, Smoc/c and
Col2-Cre are as previously described (Dietrich et al., 2000; Liu et al., 1993;
Long et al., 2001; St-Jacques et al., 1999; Zhang et al., 2001). The Col2-Cre10
line was used in this study (Long et al., 2001). All animals were genotyped by
PCR.
2.2. Morphometry
Mutant animals were first identified based on the previously known
phenotypes associated with the single mutations. The body weight of mutant
versus normal embryos was obtained immediately following dissection. Skinsamples were collected from the mutant animals and subsequently genotyped,
whereas animals with normal gross morphology were characterized as “wild
type” without genotyping. Whole mount skeletons of mouse embryos or
newborns were stained according to a protocol based on McLeod (1980). For
measurement of skeletal parameters, individual skeletal elements were dissected
from the cleared skeleton and measured under a dissecting scope. Assuming that
two single mutations cause the shortening of a skeletal element independently
by X% and Y% of normal, respectively, it is predicted that the double mutant
would exhibit a reduction of (X+Y)%.
2.3. BrdU labeling assay
For BrdU labeling experiments, pregnant females were injected with BrdU
2 h prior to sacrifice as previously described (Hu et al., 2005). The limbs were
dissected from the embryos, fixed in 10% buffered formalin overnight at room
temperature, processed and finally sectioned in paraffin. The sections were
stained for BrdU incorporation using a kit (Zymed Laboratories, CA). BrdU
labeling index was scored for multiple sections from each cartilage element. The
results reported here were from the forelimbs (digit 1 for the Igf1f n/n;Ihhn/wt, and
the DKO embryos; digit 2 for the DCKO and wild-type littermates; both the
proximal end of the ulna and digit 4 for the Igfrn/n and wild-type littermates).
2.4. Glycogen staining
Glycogen accumulation was detected by the periodic acid-Schiff (PAS)
reaction as previously described (Wang et al., 1999). Briefly, sections were
deparaffinized, rehydrated and oxidized in 0.1% periodic acid and then stained
in 0.5% Schiff's solution (Sigma) and counterstained with hematoxylin.
3. Results
3.1. Global removal of Ihh and IGF1R signaling
To determine whether Ihh and IGF signaling intersects in
regulating embryonic growth, we attempted to generate com-
pound, homozygous null mutant embryos that were Ihhn/n;
Igf1rn/n (DKO) by mating double heterozygous mice (Ihhn/wt;
Igf1rn/wt). However, in harvesting a total of 236 embryos at
E17.5–18.5, we identified only two DKO embryos, at a
recovery rate of 0.8%, approximately 1/8 of the expected
Mendelian ratio (6.25%), even though both types of single null
mutants as well as the Ihhn/wt; Igf1rn/n embryos were recovered
at, or near, expected ratios (Table 1). Moreover, Ihhn/n; Igf1rn/wt
embryos were recovered at 3%, also significantly below the
expected 12.5%. Thus, in the background of Ihhn/n, removal of
Igf1r resulted in embryonic lethality, apparently in a dose-
dependent manner. Subsequent analyses at progressively early
stages indicated that a majority of the DKO embryos died prior
to E11.5 (data not shown), but the reasons for the early lethality
were not pursued.
The DKO mutant embryos exhibited more severe growth
retardation than either single mutant. As previously described,
at E17.5, the overall size of either Ihhn/n or Igf1rn/n embryos
was significantly smaller than that of the normal littermates
(Fig. 1A). Interestingly, the DKO embryo was further reduced
in size (Fig. 1A). In particular, the body weight of the compound
mutant decreased to ~22% of the wild-type embryo, compared
to 79% and 44% with the Ihhn/n and the Igf1rn/n embryo,
respectively (Fig. 1B). Notably, the weight deficit in the DKO
embryo (78%) was equivalent to the sum of the deficits in the
single mutants (77%=21%+56%), suggesting an additive
Table 1
Breeding data (Igflrn/wt; Ihhn/wt×Igflrn/wt; Ihhn/wt)
Genotype
Igflr/Ihh





g 168 71.19 6:2512:5012:50
25:00
g56:25 NormalW: 1.025±0.03
− − / + + 19 8.00 6.25 Lacking Igflr
W: 0.45+0.04 (43.9% of normal)− − / + − 28 12.00 12.50
+ + / − − 12 5.00 6.25 Lacking Ihh
W:0.81±0.03 (79% of normal)+ − / − − 7 3.00 12.50
− − / − − 2 0.85 6.25 Lacking Iflr+ Ihh
W: 0.22 (21.5% of normal)
Average weights (W; in g) ±SEM were calculated from subsets of embryos recovered at E17.5–E18.5 (the number for normal embryos and for Igf1r, Ihh and double
nullizygotes were 4, 4, 3 and 1, respectively).
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tained all morphological features of Ihhn/n embryos, including a
severe reduction of the limbs (red arrows, Fig. 1A). Thus,
removal of IGF1R signaling in the absence of Ihh resulted in a
further decrease in body size and weight.
The exacerbated growth defect in the DKO embryo was
evident in the skeleton. As previously reported, Ihhn/n mutants
exhibit severe defects in the endochondral skeleton. In
particular, the limb skeletal elements (long bones) were very
short and disproportionally wide and failed to ossify (Fig. 1C).
The Igf1rn/n embryo, on the other hand, had long bones
proportionately shorter than normal but considerably longer
than those in the Ihhn/n mutant (Fig. 1C). Importantly, in theFig. 1. Analyses of mouse embryos with Ihh and/or Igf1r removed from all tissues.
limbs in Ihhn/n andDKO embryos. (B) Relative body weights of E17.5 embryos. The
Ihhn/n and DKO, respectively. (C) Whole mount skeletons at E17.5 stained with alcia
indicate the diminished limb skeletal elements in Ihhn/n andDKO embryos. Hind limb
magnification below the respective whole mount skeletons. (D) BrdU labeling assayDKO embryo, the long bones maintained the same morphol-
ogy as in the Ihhn/n mutant but were further reduced in size
(Fig. 1C). These results therefore revealed non-overlapping
roles between Ihh and IGF1R signaling in the regulation of
skeletal growth.
We next investigated whether Ihh and IGF1R signaling
controlled chondrocyte proliferation in an interdependent
manner. Previous studies showed that Ihhn/n embryos had a
50% loss in BrdU labeling index in chondrocytes (St-Jacques
et al., 1999), whereas Igf1r−/− fibroblasts in culture showed a
significant defect in proliferation (Sell et al., 1994). We
specifically assayed for the BrdU labeling index upon removal
of Ihh in the absence of Igf1r. In this setting, ~13.1% of the(A) Gross morphology of E17.5 embryos. Red arrows indicate the diminished
wild-type weight was designated as 1 unit. n=4, 4, 3 and 1 for wild type, Igf1rn/n,
n blue (cartilage) and alizarin red (bone and mineralized cartilage). Red arrows
s with the tibia (t) on the top and the fibula (f) at the bottom are shown at a higher
s for proliferating chondrocytes in phalanges at E17.5.
Fig. 2. Skeletons of E18.5 mouse embryos with Smo and/or Igf1r specifically
removed from the cartilage. Hind limbs with the tibia (t) on the top and the fibula
(f) at the bottom are shown at a higher magnification below the respective whole
mount skeletons.
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labeled by BrdU (Fig. 1D). However, the labeling index
dropped to ~5.6% in the DKO embryo, indicating a ~57%
reduction. Thus, proliferation was decreased to a similar extent
when Ihh activity was removed in the presence or absence of
IGF1R activity.
3.2. Cartilage-specific removal of Ihh and IGF1R signaling
In order to circumvent premature embryonic lethality and to
investigate skeleton-specific effects of Ihh and IGF signaling,
we generated mutant mice that were unable to respond to either
signal in the cartilage through removal of Smo, or Igf1r, or both
genes specifically in chondrocytes. To this end, we utilized a
Col2-Cre transgenic line (Long et al., 2001) to delete the floxed
alleles of Smo (Smoc) (Long et al., 2001) and Igf1r (Igf1rc)
(Dietrich et al., 2000). Among a total of 243 animals harvestedFig. 3. Relative lengths of skeletal elements in newborn (P0) mice. N≥3 for all gen
indicate that there is a statistically significant difference between genotypes in pairwis
significantly from the predicted values based on independent signaling by Ihh and Iat birth (P0) from crosses between Col2-Cre; Smon/wt; Igf1rn/wt,
and Smoc/wt; Igf1rc/wt, five were identified as double conditional
knockout mutants (DCKO) (2.1%), approximating the expected
ratio (~3.1%).
The DCKOmice exhibited a further reduction in the skeleton
compared with that of either single conditional knockout
animal. Specifically, whereas the Igf1r-CKO mutant exhibited
proportionately shorter elements and the Smo-CKO animals
contained shortened and misshapen long bones, the limb
skeletal elements of the DCKO littermates were both misshapen
and further reduced (Fig. 2). Thus, as observed with elimination
of Ihh and Igf1r in the entire animal, cartilage-specific removal
of the Ihh and IGF responsiveness resulted in a further reduction
in the size of the skeleton.
To determine whether the exacerbated phenotype in the
DCKO animals represented additive or synergistic effects
between the single mutations, we measured the linear length
of individual skeletal elements and compared them across
genotypes. In newborn animals (P0), depending on the
individual element, the Igf1r-CKO and the Smo-CKO mice
showed a 10–20% or a 30–50% reduction over the wild type,
respectively (Fig. 3). As expected from earlier analyses, the
DCKO mutants exhibited a further diminution in the length of
skeletal elements. Interestingly, the lengths of the DCKO
elements approximated the theoretical values predicted from
independent signaling (see Materials and methods). Thus,
disruption of both Ihh and IGF1R signaling in the cartilage
appeared to result in an additive defect in skeletal growth.
We next compared the morphology of the growth plate
among embryos with the different genotypes. At E18.5, the
growth plate of a normal femur was organized in distinct
regions containing round cells (“R”), flattened cells (“C”,
organized in columns), and hypertrophic cells (“H”) (Fig. 4A).
The growth plate in the Igf1r-CKO mouse, although shorter and
narrower, maintained a general organization similar to that inotypes. The wild type length for each element is designated as 1 unit. Asterisks
e comparisons (p<0.05). The actual lengths of the DCKO elements do not differ
GF1R.
Fig. 4. Growth plate morphology and chondrocyte proliferation at E18.5. (A–D) Histology of the growth plate of the femur in wild-type (A), Igf1r-CKO (B), Smo-
CKO (C) and DCKO (D) embryos. (A1–D1) Areas in green boxes in panels A–D, respectively, shown at a higher magnification. (A2–D2) Areas in blue boxes in
panels A–D, respectively, shown at a higher magnification. R: round chondrocytes; C: columnar chondrocytes; H: hypertrophic chondrocytes. Blue arrows: flat
chondrocytes; red arrows: round chondrocytes. (E) BrdU labeling index in the phalanges of DCKO versus wild-type embryos at E18.5. *p<0.05.
331F. Long et al. / Developmental Biology 298 (2006) 327–333the wild-type embryo (Fig. 4B). At a higher magnification, the
flattened cells (blue arrows) can be seen in stacks in both the
wild-type and the Igf1r-CKO embryos (Fig. 4, A1 and B1
respectively). However, the size of individual hypertrophic
chondrocytes appeared smaller in the Igf1r-CKO embryo than
in the wild-type littermate (Fig. 4, B2 and A2 respectively), as
described previously (Wang et al., 1999). Remarkably, in the
Smo-CKO mouse, the growth plate had virtually no columnar
region, even though the regions for the round cells and the
hypertrophic chondrocytes were maintained (Fig. 4C). Instead,
the equivalent of the columnar region was now disorganized
and contained both round (red arrow) and flattened (blue arrow)
cells (Fig. 4, C1). Finally, the growth plate in the DCKO
embryo was overall similar to that in the Smo-CKO littermate,
and it too lacked an obvious columnar region (Fig. 4, D and
D1). Thus, removal of Smo leads to the loss of a distinct
columnar region in the growth plate with or without IGF
signaling.
To confirm the proliferation defect in chondrocytes lacking
both Ihh and IGF signaling, we performed BrdU labeling
experiments in DCKO and wild-type littermates. At E18.5, the
DCKO embryos showed a ~50% reduction in the labeling
percentage in the phalanges when compared to wild-type
controls (Fig. 4E). Interestingly, at the same embryonic stage,
the Igf1rn/n embryo showed no reduction in BrdU labeling in
either the phalanges or the ulna in comparison with the wild-
type level (data not shown; see Discussion). Thus, regardless ofthe status of IGF signaling, elimination of Ihh signaling
significantly reduces the BrdU labeling index in chondrocytes.
Parallel signaling by Ihh and IGF1R would predict normal
signaling by Ihh or IGF1R in animals with Igf1r or Ihh
deficiency, respectively. The normal morphology of the growth
region cartilage in the Igf1rn/n or the Igf1r-CKO mutant
(Fig. 5, B1) is consistent with normal Ihh production and
signaling. In order to determine whether IGF signaling was
affected in chondrocytes in the absence of Ihh, we examined
glycogen accumulation as a functional readout for IGF
signaling (Wang et al., 1999). At E17.5, abundant glycogen
was detected in both proliferating and prehypertrophic
chondrocytes of a normal embryo (Fig. 5, A1 and A2), but
as expected, this was significantly diminished in the Igf1r-
CKO mutant (Fig. 5, B1 and B2). Importantly, glycogen levels
in the non-hypertrophic chondrocytes of the Ihhn/n embryo
were not reduced from wild-type levels (Fig. 5, C1 and C2).
As a control, glycogen levels in the skeletal muscle were
unchanged across the three genotypes (Fig. 5, A3–C3). These
results support the conclusion of functional IGF signaling in
the absence of Ihh signaling in chondrocytes.
4. Discussion
We have tested genetically the hypothesis that systemic
growth signals may function by modulating signaling by local
factors in individual target tissues. In particular, we addressed
Fig. 5. Glycogen accumulation in growth region chondrocytes. Glycogen was stained in magenta. Boxed regions in (A1–C1) are shown at a higher magnification in
(A2–C2), respectively. Skeletal muscles from the same sections are shown as control for the staining procedure (C1–C3). H: hypertrophic chondrocytes.
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growth of the skeleton. By disrupting both signaling pathways
either globally (Ihhn/n; Igf1rn/n) or specifically in the skeleton
(Col2-Cre; Smon/c; Igf1rn/c), the evidence suggests that IGFs
and Ihh most likely signal independently in the regulation of
skeletal growth.
Disruption of either IGF or Ihh signaling pathway resulted in
pups developing a smaller skeleton. It should be noted that the
two mutant skeletons exhibited apparent differences from each
other in their gross morphology. Whereas bones in either Igf1n/n
or Igf1rn/n mice were proportionately smaller than normal,
skeletal elements in the Ihhn/n mice were more severely reduced
and disproportionately wider. The milder phenotype resulting
from defective IGF signaling could incorporate a partial
disruption of Ihh signaling (IGF upstream of Ihh), or Ihh
could regulate skeletal growth in part by controlling IGF
signaling (Ihh upstream of IGF). These scenarios would predict
that the compound mutant recapitulates the Ihhn/n phenotype.
However, our studies revealed that loss of both signals resulted
in an additive reduction in the lengths of long bones. Therefore,
these observations support an alternative conclusion that Ihh
and IGF1R most likely signal independently to control skeletal
growth.
The independence between Ihh and IGF may indicate
distinct mechanisms utilized by the two signals in regulating
skeletal growth. In particular, Ihh and IGF may control
chondrocyte proliferation by different means, as BrdU pulse
labeling experiments consistently revealed an ~50% reduction
in the labeling index in cells lacking Ihh signaling but failed to
detect a deficit in the proliferating Igf1rn/n chondrocytes. The
normal BrdU labeling index indicates that the S phase was not
reduced in relation to other phases of the cell cycle in the
Igf1rn/n cells. However, it is possible that all phases of the cell
cycle were prolonged in the Igf1rn/n chondrocytes, resulting ina longer total cell cycle time and hence a reduction in
proliferation. Indeed, a previous study showed that Igf1rn/n
embryonic fibroblasts in culture exhibited a cell cycle time
more than twice that of normal fibroblasts, with all phases of
the cell cycle prolonged and the relative portion of the S phase
unchanged (Sell et al., 1994). Notably, the previous study also
reported that pulse labeling experiments with [3H]thymidine
did not detect any difference between the wild-type and the
Igf1rn/n fibroblasts in culture (Sell et al., 1994).
In addition to its role in chondrocyte proliferation, Ihh may
also directly regulate chondrocyte morphology. In support of
this notion, removal of Ihh responsiveness (Smo-CKO)
resulted in a dramatic reduction in the number of flattened
cells and the absence of a distinct columnar region. The
regulation of cell morphology may be independent of
chondrocyte maturation, as the latter appeared largely normal
in these animals (Long et al., 2001). Alternatively, loss of the
columnar region could be secondary to the marked decrease in
cell number in the absence of Ihh signaling as cells within this
region normally exhibit both the highest proliferation rate and
the most robust Ihh signaling within the growth plate (Long
et al., 2001). Regardless of the mechanism, this finding is
consistent with a model wherein Ihh, independent of PTHrP,
promotes the length of the columnar region in the growth plate
(Kobayashi et al., 2005).
Our studies revealed that removal of Igf1r specifically in
collagen-II-expressing cells (chondrocytes and osteoblast
progenitors) resulted in significant growth retardation in long
bones. In contrast, specific deletion of Igf1r in mature
osteoblasts by osteocalcin-Cre resulted predominantly in
mineralization defects without obvious growth deficits (Zhang
et al., 2002). Thus, it appears that IGF signaling modulates
skeletal growth chiefly by acting on chondrocytes and possibly
osteoblast precursors.
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